Tarchomin Pharmaceutical Works "Polfa" S.A.
Acronym: TZF
General Information
Identification Code: 316556891811-84
Website: [object Object]
Entity Form: S.A. (plc)
Registration Category: Companies & groups
Registration Date: 4/19/2024
EP Accredited Number: 0
Mission & Interests
Goals: Polish generic pharmaceutical company, producer of APIs and FDFs critical for European and international markets. Company with 200 years of history in pharma business. The only polish penicillin's manufacturer, a strong player in antibiotics market, producer of human insulin, highly experienced in sterile production. We heavily invest in new state of the art production facility dedicated to hilgly potent drugs.
Interests Represented: Promotes their own interests or the collective interests of their members
Interests:
- Budget
- Climate action
- Public health
- Research and innovation
Levels of Interest:
- national
- european
- global
- sub-national
Activities
Main EU Legislative Proposals: EMA/528805/2023 Union list of critical medicines - version 1
Vulnerabilities in critical medicines supply chains
Communication Activities: https://www.ema.europa.eu/en/news/first-version-union-list-critical-medicines-agreed-help-avoid-potential-shortages-eu
https://health.ec.europa.eu/health-emergency-preparedness-and-response-hera_en
https://health.ec.europa.eu/health-emergency-preparedness-and-response-hera/overview/critical-medicines-alliance_en
https://www.edqm.eu/en/groups-of-experts-and-working-parties
Inter-institutional or Unofficial Groupings: N/A
Head Office
Address: Fleminga 2
Post Code: 03-176
City: Warszawa
Country: POLAND
Phone: [object Object]
EU Office
Address: Fleminga 2
Post Code: 03-176
City: Warszawa
Country: POLAND
Phone: [object Object]
Financial Data
New Organisation: false
Closed Year: [object Object]
Current Year: [object Object]
Membership Information
Members10 Percent: 4
Members25 Percent: 0
Members50 Percent: 0
Members75 Percent: 0
Members: 4
Members F T E: 0.4000000059604645
Info Members: 4 people work in close cooperation with HEAR at data collection survey for the pilot phase of the critical medicines vulnerability analysis to collect necessary data and work as EDQM experts in working groups.
Their percentage involvement regarding to full time job is estimated for 10%.
Structure
Structure Type: Structure
Is Member Of: Małgorzata Stokrocka - Expert in EDQM Working Group
Rafał Łunio - Expert in EDQM Working Group
Monika Janicka - Expert in EDQM Working Group
Organisation Members: EDQM